RGEN
Repligen Corporation
Stock
$181.70+4.47 (+2.52%)Close Oct 2, 2026
- Research and development, 2025
- $54M
- YoY, 2025
- +25.4%
- 5-year CAGR
- +21.8%
- 10-year CAGR
- +25.2%
Research and development
Research and development by fiscal year
| Period | R&D | YoY |
|---|---|---|
| 2025 | $54M | +25.4% |
| 2024 | $43M | +1.1% |
| 2023 | $43M | −2.8% |
| 2022 | $44M | +28.2% |
| 2021 | $34M | +69.8% |
| 2020 | $20M | +3.8% |
| 2019 | $19M | +22.9% |
| 2018 | $16M | +82.4% |
| 2017 | $8.7M | +17.9% |
| 2016 | $7.4M | +28.1% |
| 2015 | $5.7M | +2.3% |
| 2014 | $5.6M | −23.6% |
| 2013 | $7.3M | −30.0% |
| 2012 | $10M | — |
| 2011 | $13M | −11.5% |
| 2010 | $14M | — |